From: Variation at APOE and STH loci and Alzheimer's disease
allele/genotype | PPV [ (AD|ε)] | LR+ | LR range1 | Significance for diagnosis |
---|---|---|---|---|
 |  |  | > 10 | greatly increasing risk for AD |
 |  |  | 5~ 10 | moderately increasing risk for AD |
ε 4/ε 4 | 39.90% | 3.76 | 2~ 5 | small increase in risk for AD |
ε 4 | 31.50% | 2.60 |  |  |
ε 3/ε 4 | 28.80% | 2.29 |  |  |
 |  |  | 1~ 2 | minimally increasing risk for AD |
 | 15.00% (population prevalence) |  | 1 | no change in risk for AD |
ε 3 | 12.00% | 0.77 | 0.5~ 1 | minimally decreasing risk for AD |
ε 2/ε 4 | 10.82% | 0.69 |  |  |
ε 3/ε 3 | 9.40% | 0.59 |  |  |
ε 2 | 6.50% | 0.39 | 0.2~ 0.5 | small decrease in risk for AD |
ε 2/ε 3 | 5.70% | 0.34 |  |  |
 |  |  | 0.1~ 0.2 | moderately decreasing risk for AD |
 |  |  | < 0.1 | greatly decreasing risk for AD |